Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Workers - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
4.9 mg/m³
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
25
Dose descriptor starting point:
NOAEL
Value:
70 mg/kg bw/day
Modified dose descriptor starting point:
other: NAEC human worker
Value:
122.5 mg/m³
Explanation for the modification of the dose descriptor starting point:

[(NOEL/4) x 70]/10; NOEL= 70 mg/kg bw day; 4= allometric scaling factor for rat; 70 kg/bw: mean human body weight; 10 mg/m^3 air default worker breathing volume

AF for dose response relationship:
1
Justification:
Sufficient data about curve of dose/response. No additional severity factor.
AF for differences in duration of exposure:
2
Justification:
From sub chronic to chronic (OECD422 56 days)
AF for interspecies differences (allometric scaling):
1
Justification:
No allometric scaling needed because the starting point (NAEC human worker) has just been corrected for the human evaluation.
AF for other interspecies differences:
2.5
Justification:
Additional factor for other interspecies differences ( i.e. toxicokinetic differences not related to metabolic rate (small part) and toxicodynamic differences (larger part). Remaining differences.
AF for intraspecies differences:
5
Justification:
For workers, as standard procedure for threshold effects a default assessment factor of 5 is to be used, based on the fact that this sub population does not cover the very young, the very old, and the very ill.
AF for the quality of the whole database:
1
Justification:
GLP compliant with OECD and EU guidelines.
AF for remaining uncertainties:
1
Justification:
100% absorption for the inhalative route for animals and humans is assumed.
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Workers - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
0.7 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
100
Modified dose descriptor starting point:
NOAEL
Value:
70 mg/kg bw/day
Explanation for the modification of the dose descriptor starting point:
Repeated oral study is the best way to assess the dermal route in absence of a repeated dermal study.
AF for dose response relationship:
1
Justification:
Sufficient data about curve of dose/response. No additional severity factor.
AF for differences in duration of exposure:
2
Justification:
From sub chronic to chronic (OECD422 56 days)
AF for interspecies differences (allometric scaling):
4
Justification:
rat to human
AF for other interspecies differences:
2.5
Justification:
Additional factor for other interspecies differences ( i.e. toxicokinetic differences not related to metabolic rate (small part) and toxicodynamic differences (larger part). Remaining differences.
AF for intraspecies differences:
5
Justification:
For workers, as standard procedure for threshold effects a default assessment factor of 5 is to be used, based on the fact that this sub population does not cover the very young, the very old, and the very ill.
AF for the quality of the whole database:
1
Justification:
GLP compliant with OECD and EU guidelines.
AF for remaining uncertainties:
1
Justification:
Assuming 100% of absorption
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
Value:
2 000 mg/kg bw/day
Most sensitive endpoint:
acute toxicity
Route of original study:
Dermal
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified

Workers - Hazard for the eyes

Local effects

Hazard assessment conclusion:
low hazard (no threshold derived)

Additional information - workers

General Population - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
1.225 mg/m³
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
50
Modified dose descriptor starting point:
other: NAEC General population
Value:
61.25 mg/m³
Explanation for the modification of the dose descriptor starting point:
NAEC(oral rat - Human gen. population)= [70 mg/kg bw( NOAEL)/4 ((assessment factor interspecies) X 70 kg (human body weight): 20 m^3 (24h human breathing volume)]= 61.25 mg/m^3
AF for dose response relationship:
1
Justification:
Sufficient data about curve of dose/response. No additional severity factor.
AF for differences in duration of exposure:
2
Justification:
From sub chronic to chronic (OECD422 56 days)
AF for interspecies differences (allometric scaling):
1
Justification:
No allometric scaling needed because the starting point (NAEC human worker) has just been corrected for the human evaluation.
AF for other interspecies differences:
2.5
Justification:
Additional factor for other interspecies differences ( i.e. toxicokinetic differences not related to metabolic rate (small part) and toxicodynamic differences (larger part). Remaining differences.
AF for intraspecies differences:
10
Justification:
For threshold effects, this factor of 10 is the standard procedure, as a default, when assessing exposure to the general population. It is recognised that there re differences between children and adults in toxicokinetics (especially babies in their first months) and toxicodynamics (especially at different stages of development). These differences may render children more or less susceptible to the toxic effects of a substance.
AF for the quality of the whole database:
1
Justification:
GLP compliant with OECD and EU guidelines.
AF for remaining uncertainties:
1
Justification:
100% absorption for the inhalative route for animals and humans is assumed.
Acute/short term exposure
Hazard assessment conclusion:
high hazard (no threshold derived)
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
high hazard (no threshold derived)
Acute/short term exposure
Hazard assessment conclusion:
high hazard (no threshold derived)
DNEL related information

General Population - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
0.35 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
200
Modified dose descriptor starting point:
NOAEL
Value:
70 mg/kg bw/day
Explanation for the modification of the dose descriptor starting point:

repeated oral study is the best way to assess the dermal route in absence of a repeated dermal stud Repeated oral study is the best way to assess the dermal route in absence of a repeated dermal study

Repeated oral study is the best way to assess the dermal route in absence of a repeated dermal study. Repeated oral study is the best way to assess the dermal route in absence of a repeated dermal study.

AF for dose response relationship:
1
Justification:
Sufficient data about curve of dose/response. No additional severity factor.
AF for differences in duration of exposure:
2
Justification:
From sub chronic to chronic (OECD422 56 days)
AF for interspecies differences (allometric scaling):
4
Justification:
rat to human
AF for other interspecies differences:
2.5
Justification:
Additional factor for other interspecies differences ( i.e. toxicokinetic differences not related to metabolic rate (small part) and toxicodynamic differences (larger part). Remaining differences.
AF for intraspecies differences:
10
Justification:
For threshold effects, this factor of 10 is the standard procedure, as a default, when assessing exposure to the general population. It is recognised that there are differences between children and adults in toxicokinetics (especially babies in their first months) and toxicodynamics (especially at different stages
of development). These differences may render children more or less susceptible to the toxic effects of a substance.
AF for the quality of the whole database:
1
Justification:
GLP compliant with OECD and EU guidelines.
AF for remaining uncertainties:
1
Justification:
Assuming 100 % absorption
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
high hazard (no threshold derived)
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified

General Population - Hazard via oral route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
0.35 mg/kg bw/day
Most sensitive endpoint:
repeated dose toxicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
200
Modified dose descriptor starting point:
NOAEL
Value:
70 mg/kg bw/day
AF for dose response relationship:
1
Justification:
Sufficient data about curve of dose/response. No additional severity factor.
AF for differences in duration of exposure:
2
Justification:
subchronic to chronic From sub chronic to chronic (OECD422 56 days)
AF for interspecies differences (allometric scaling):
4
Justification:
rat to human
AF for other interspecies differences:
2.5
Justification:
Additional factor for other interspecies differences ( i.e. toxicokinetic differences not related to metabolic rate (small part) and toxicodynamic differences (larger part). Remaining differences.
AF for intraspecies differences:
10
Justification:
For threshold effects, this factor of 10 is the standard procedure, as a default, when assessing exposure to the general population. It is recognised that there are differences between children and adults in toxicokinetics (especially babies in their first months) and toxicodynamics (especially at different stages of development). These differences may render children more or less susceptible to the toxic effects of a substance.
AF for the quality of the whole database:
1
Justification:
GLP compliant with OECD and EU guidelines
AF for remaining uncertainties:
1
Justification:
Assuming 100 % absorption
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

General Population - Hazard for the eyes

Local effects

Hazard assessment conclusion:
low hazard (no threshold derived)

Additional information - General Population